Intraoperative Longitude-Latitude-Depth Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for 0.8-2 cm Peripheral Pulmonary Nodules

The goal of this clinical trial is to learn whether intraoperative longitude-latitude-depth three-dimensional localization (LLD localization) is non-inferior to preoperative CT-guided percutaneous lung puncture localization for identifying 0.8-2 cm peripheral pulmonary nodules in adults undergoing video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection. It will also evaluate the safety and perioperative effectiveness of the two localization methods. The main questions it aims to answer are: 1. Is the localization accuracy rate of LLD localization non-inferior to that of CT-gui

Trial Details

NCT ID
NCT07675889
Phase
NA
Sponsor
Qilu Hospital of Shandong University
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Longitude-Latitude-Depth Localization
  • CT-Guided Percutaneous Lung Puncture Localization
Locations (sample)
  • Xingyi, Guizhou, China|25.09617,104.90639
  • Yinchuan, Ningxia, China|38.46806,106.27306
  • Jinan, Shandong, China|36.66833,116.99722
  • Linqing, Shandong, China|36.84092,115.71087

Key Eligibility Criteria

  • Clinically diagnosed pulmonary nodule by non-contrast chest CT.
  • Age 18 to 80 years.
  • Expected survival time of at least 12 months.
  • Single peripheral pulmonary nodule with a diameter between 0.8 cm and 2 cm.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →